TET2 and lung carcinoma: [80] describe a mouse model in which TET2 mutated tumor infiltrating lymphocytes (TILs) derived from clonal hematopoiesis stimulate tumor angiogenesis in lung cancer, exacerbating tumorigenesis and promoting metastasis.